HomeComparePMKRF vs MRK

PMKRF vs MRK: Dividend Comparison 2026

PMKRF yields 369.28% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PMKRF wins by $6411.56M in total portfolio value
10 years
PMKRF
PMKRF
● Live price
369.28%
Share price
$0.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6411.59M
Annual income
$4,183,188,765.17
Full PMKRF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PMKRF vs MRK

📍 PMKRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMKRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMKRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMKRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMKRF
Annual income on $10K today (after 15% tax)
$31,388.48/yr
After 10yr DRIP, annual income (after tax)
$3,555,710,450.39/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, PMKRF beats the other by $3,555,709,642.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMKRF + MRK for your $10,000?

PMKRF: 50%MRK: 50%
100% MRK50/50100% PMKRF
Portfolio after 10yr
$3205.81M
Annual income
$2,091,594,857.73/yr
Blended yield
65.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PMKRF
No analyst data
Altman Z
1.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMKRF buys
0
MRK buys
0
No recent congressional trades found for PMKRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMKRFMRK
Forward yield369.28%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$6411.59M$30.7K
Annual income after 10y$4,183,188,765.17$950.29
Total dividends collected$6201.89M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PMKRF vs MRK ($10,000, DRIP)

YearPMKRF PortfolioPMKRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$47,628$36,927.62$11,192$351.54+$36.4KPMKRF
2$215,333$164,371.48$12,524$392.70+$202.8KPMKRF
3$924,942$694,535.49$14,015$438.65+$910.9KPMKRF
4$3,777,827$2,788,139.05$15,682$489.96+$3.76MPMKRF
5$14,685,133$10,642,858.16$17,547$547.23+$14.67MPMKRF
6$54,377,408$38,664,315.99$19,632$611.16+$54.36MPMKRF
7$191,987,235$133,803,408.68$21,963$682.53+$191.97MPMKRF
8$646,932,994$441,506,651.74$24,571$762.18+$646.91MPMKRF
9$2,082,620,417$1,390,402,113.47$27,486$851.08+$2082.59MPMKRF
10$6,411,592,611$4,183,188,765.17$30,745$950.29+$6411.56MPMKRF

PMKRF vs MRK: Complete Analysis 2026

PMKRFStock

Playmaker Capital Inc. operates as a digital sports media company that lives at the intersection of sports, betting, media, and technology. The company is headquartered in Toronto, Canada.

Full PMKRF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PMKRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMKRF vs SCHDPMKRF vs JEPIPMKRF vs OPMKRF vs KOPMKRF vs MAINPMKRF vs JNJPMKRF vs ABBVPMKRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.